Extracellular Signal-Regulated Kinases
Showing 1 - 25 of 2,976
Pancreatic Ductal Adenocarcinoma Trial (combination therapy with no MEKi, combination therapy with MEKi-HCQ, combination therapy
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- combination therapy with no MEKi
- +3 more
- (no location specified)
Nov 29, 2022
Rechallenge of BRAF +/- MEK Inhibitors FollowingAdverse Event in
Active, not recruiting
- Cancer
- BRAF inhibitor
- (no location specified)
Oct 13, 2021
Acne Scars - Mixed Atrophic and Hypertrophic Trial (microneedling, microneedling with topical timolol 0.5%)
Not yet recruiting
- Acne Scars - Mixed Atrophic and Hypertrophic
- microneedling
- microneedling with topical timolol 0.5%
- (no location specified)
Oct 25, 2022
Pancreatic Cancer, Advanced Cancer Trial in Boston, Chapel Hill (Hydroxychloroquine Sulfate, LY3214996)
Recruiting
- Pancreatic Cancer
- Advanced Cancer
- Hydroxychloroquine Sulfate
- LY3214996
-
Boston, Massachusetts
- +2 more
Apr 6, 2022
Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Binimetinib Oral Tablet
Not yet recruiting
- Adamantinous Craniopharyngioma
- Recurrent Adamantinomatous Craniopharyngioma
- Binimetinib Oral Tablet [Mektovi]
-
Aurora, Colorado
- +17 more
Nov 28, 2022
Chemo Induced Peripheral Neuropathy Trial (Omeprazole)
Not yet recruiting
- Chemotherapy Induced Peripheral Neuropathy
- (no location specified)
Jan 10, 2023
Depressive Disorder, Treatment-Resistant, Depressive Disorder, Major Trial in Shanghai (Sevoflurane, Placebo)
Not yet recruiting
- Depressive Disorder, Treatment-Resistant
- Depressive Disorder, Major
- Sevoflurane
- Placebo
-
Shanghai, Shanghai, ChinaShanghai First Maternity and Infant Hospital, Tongji University
Aug 12, 2021
Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- Trametinib
- +2 more
-
Miami, FloridaUniversity of Miami
Jun 27, 2022
Wound of Skin, Wound Heal, Surgical Wound Trial in Boston (0.25% timolol gel with full-thickness skin grafts, Vaseline dressing)
Terminated
- Wound of Skin
- +3 more
- 0.25% timolol gel with full-thickness skin grafts
- Vaseline dressing
-
Boston, MassachusettsMohs and Dermatologic Surgery Center, Brigham and Women's Hospit
Jan 10, 2022
Advanced and Selected Solid Tumors Trial in Worldwide (BKM120, GSK1120212)
Completed
- Advanced and Selected Solid Tumors
-
Los Angeles, California
- +6 more
Dec 6, 2020
COVID-19 Pneumonia Trial in Wenzhou (Extracellular Vesicles from Mesenchymal Stem Cells)
Recruiting
- COVID-19 Pneumonia
- Extracellular Vesicles from Mesenchymal Stem Cells
-
Wenzhou, Zhejiang, ChinaThe First Affiliated Hospital of Wenzhou Medical University
Mar 27, 2023
Advanced Cancer, Metastatic Melanoma, Metastatic NSCLC Trial in Worldwide (LY3214996, Midazolam, Abemaciclib)
Active, not recruiting
- Advanced Cancer
- +3 more
- LY3214996
- +6 more
-
Washington, District of Columbia
- +12 more
Sep 2, 2021
Low-grade Glioma, Plexiform Neurofibroma, CNS Glioma Trial in Canada (Trametinib)
Active, not recruiting
- Low-grade Glioma
- +2 more
-
Calgary, Alberta, Canada
- +6 more
Oct 25, 2022
Non-Metastatic Adenocarcinoma of the Rectum Trial run by the NCI (Radiation Therapy, Capecitabine, AZD6244)
Terminated
- Non-Metastatic Adenocarcinoma of the Rectum
- Radiation Therapy
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 1, 2021
MEK Inhibitor-Associated Serous Retinopathy Trial in Paris (OCT-B scan)
Recruiting
- MEK Inhibitor-Associated Serous Retinopathy
- OCT-B scan
-
Paris, FranceFondation A de Rothschild
Jan 24, 2022
IgG Dependent Monocyte Activation in Proximal Venous
Completed
- Venous Thromboembolism
- Pulmonary Embolism
- Blood sampling
-
Montpellier cedex 5, France
- +1 more
Jun 29, 2020
Pancreatic Cancer, Cancer of Pancreas, Cancer of the Pancreas Trial in Saint Louis (BVD-523, Nab-paclitaxel, Gemcitabine)
Terminated
- Pancreatic Cancer
- +3 more
- BVD-523
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Apr 19, 2021
COVID-19 Trial in Edison (Omega-3 (EPA+DHA), Placebo)
Recruiting
- COVID-19
- Omega-3 (EPA+DHA)
- Placebo
-
Edison, New JerseyHackensack Meridian Health
Dec 13, 2022
BRAF V600E Mutation Trial run by the NHGRI (Dabrafenib Mesylate, Trametinib Dimethyl Sulfoxide)
Completed
- BRAF V600E Mutation
- Dabrafenib Mesylate
- Trametinib Dimethyl Sulfoxide
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 6, 2021
Thyroid Gland Anaplastic Carcinoma Trial in Saint Petersburg (Dabrafenib, Trametinib)
Recruiting
- Thyroid Gland Anaplastic Carcinoma
-
Saint Petersburg, Russian FederationSaint-Petersburg State University (SPSU) N.I.Pirogov Clinic of H
Feb 3, 2021
(POPAS) Study Using RS-4i Sequential Stimulator With Intersperse
Not yet recruiting
- Osteoarthritis
- RS-4i Plus
- (no location specified)
Jul 27, 2022
Nurse's Role, Motivation Trial (digital learning in motivational interviewing)
Not yet recruiting
- Nurse's Role
- Motivation
- digital learning in motivational interviewing
- (no location specified)
Aug 16, 2023